Dr. Edwin C. Ferren, MD
Pediatrics (Pediatrics Physician)
1001 Blythe Blvd, Medical Center Plaza Suite 200
Charlotte, NC 28203
At a glance
- Years since graduation
- 11
- In the NPI registry since
- 2015
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatrics Physician primary
NC license 2020-03526 -
Clinical Biochemical Genetics Physician
NC license 2020-03526 -
Clinical Genetics (M.D.) Physician
NC license 2020-03526
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Carolinas Medical Center/behav Health Charlotte, NC
Medical groups
- Carolinas Physicians Network Inc (2,325 clinicians)
- Carolinas Medical Center (1,067 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 9 companies reported 41 payments worth $27,695 in total to this clinician.
| Mirum Pharmaceuticals, Inc. | $27,374 |
|---|---|
| BioMarin Pharmaceutical Inc. | $116 |
| Chiesi USA, Inc. | $63.44 |
| Ptc Therapeutics, Inc. | $33.44 |
| Genzyme Corporation | $25.18 |
| Amicus Therapeutics, Inc. | $24.18 |
| Eton Pharmaceuticals, Inc. | $23.15 |
| Cycle Pharmaceuticals Inc | $19.37 |
| Consulting Fee | $24,383 |
|---|---|
| Travel and Lodging | $2,367 |
| Food and Beverage | $944 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. Feb 12, 2025 | Consulting Fee CHOLBAM · Rare Disease | $4,500 |
| Mirum Pharmaceuticals, Inc. May 19, 2025 | Consulting Fee CHOLBAM · Rare Disease | $4,276 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Consulting Fee CHOLBAM · Rare Disease | $3,080 |
| Mirum Pharmaceuticals, Inc. Sep 16, 2025 | Consulting Fee CHOLBAM · Rare Disease | $3,080 |
| Mirum Pharmaceuticals, Inc. Mar 18, 2025 | Consulting Fee CHOLBAM · Rare Disease | $2,600 |
| Mirum Pharmaceuticals, Inc. May 20, 2025 | Consulting Fee CHOLBAM · Rare Disease | $1,925 |
| Mirum Pharmaceuticals, Inc. Feb 15, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to New Orleans, LA | $1,044 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $801 |
| Mirum Pharmaceuticals, Inc. Jul 18, 2025 | Consulting Fee Livmarli · Alagille syndrome | $770 |
| Mirum Pharmaceuticals, Inc. Jun 13, 2025 | Consulting Fee CHOLBAM · Rare Disease | $770 |
All 25 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. Oct 2, 2025 | Consulting Fee Livmarli · Alagille syndrome | $325 |
| Mirum Pharmaceuticals, Inc. Oct 2, 2025 | Consulting Fee Livmarli · Alagille syndrome | $163 |
| Mirum Pharmaceuticals, Inc. Sep 16, 2025 | Consulting Fee CHOLBAM · Rare Disease | $3,080 |
| Mirum Pharmaceuticals, Inc. Aug 1, 2025 | Consulting Fee CHOLBAM · Rare Disease | $338 |
| Mirum Pharmaceuticals, Inc. Jul 18, 2025 | Consulting Fee Livmarli · Alagille syndrome | $770 |
| Mirum Pharmaceuticals, Inc. Jul 14, 2025 | Consulting Fee CHOLBAM · Rare Disease | $450 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Consulting Fee CHOLBAM · Rare Disease | $3,080 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $801 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $324 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $64.00 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $39.23 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $32.92 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $31.70 |
| Mirum Pharmaceuticals, Inc. Jun 20, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Boston, MA | $29.92 |
| Mirum Pharmaceuticals, Inc. Jun 13, 2025 | Consulting Fee CHOLBAM · Rare Disease | $770 |
| Mirum Pharmaceuticals, Inc. Jun 1, 2025 | Consulting Fee CHOLBAM · Rare Disease | $675 |
| Mirum Pharmaceuticals, Inc. May 20, 2025 | Consulting Fee CHOLBAM · Rare Disease | $1,925 |
| Mirum Pharmaceuticals, Inc. May 19, 2025 | Consulting Fee CHOLBAM · Rare Disease | $4,276 |
| Mirum Pharmaceuticals, Inc. May 8, 2025 | Consulting Fee CHOLBAM · Rare Disease | $385 |
| Mirum Pharmaceuticals, Inc. Mar 18, 2025 | Consulting Fee CHOLBAM · Rare Disease | $2,600 |
| Mirum Pharmaceuticals, Inc. Mar 13, 2025 | Consulting Fee CHOLBAM · Rare Disease | $325 |
| Mirum Pharmaceuticals, Inc. Feb 15, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to New Orleans, LA | $1,044 |
| Mirum Pharmaceuticals, Inc. Feb 12, 2025 | Consulting Fee CHOLBAM · Rare Disease | $4,500 |
| Mirum Pharmaceuticals, Inc. Jan 9, 2025 | Consulting Fee CHOLBAM · Rare Disease | $385 |
| Mirum Pharmaceuticals, Inc. Jan 1, 2025 | Consulting Fee CHOLBAM · Rare Disease | $338 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $27,625 in research payments for these studies, mostly to the institutions running them.
- BMN 111-211
BioMarin Pharmaceutical Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.